Related Experiment Video
Updated: Sep 16, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
Patient-reported outcomes (PROs) as personalised cancer care: report from a 2023 Australian consensus meeting
Carolyn G Mazariego1, Sandra Avery2, Geoffrey P Delaney2,3,4
1Implementation to Impact (i2i), School of Population Health, Faculty of Medicine and Health, UNSW Sydney, NSW, Australia.
Abstract:
This viewpoint reports on the outcomes of the 2023 Australian interest holder meeting on the use of patient-reported outcomes (PROs) in cancer care and discusses its findings in the context of the significant national investment into the collection of PRO data in Australia. The interest holders emphasised the importance for PRO data collection to be relevant to the care of individual patients and personalised to their needs and preferences to ensure direct impact on patients' care and outcomes. They also prioritised the coordination and integration of various PRO collection efforts to improve patient outcomes and care quality.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Survival Analysis
Treatment Resistant Cancers
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Patient-centered Care

